Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus - PubMed (original) (raw)
Affiliations
- PMID: 8106963
Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus
T Wrin et al. J Acquir Immune Defic Syndr (1988). 1994 Mar.
Abstract
Although laboratory-adapted strains of human immunodeficiency virus (HIV) are generally highly sensitive to neutralization by HIV-positive patient sera, we have found a more complex pattern of cross-neutralization and neutralization resistance among low-passage clinical isolates. These HIV isolates, like many other lentiviruses, resisted neutralization by the patient's own (autologous) antibodies. We assessed the degree of antigenic relatedness between different patient isolates of HIV through cross-neutralization with heterologous sera and virus isolates. Complicated patterns emerged, with variation in breadth of neutralization among individual plasmas and variation in frequency of neutralization among isolates. In longitudinal studies of individuals, we found that some but not all such patients develop a neutralizing response that "catches up" with their earlier isolates after a lag period. Taken together, these data suggest that an individual's immune response broadens with time because of cumulative exposure to multiple antigenic variants that arise throughout HIV disease.
Similar articles
- Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.
Deeks SG, Schweighardt B, Wrin T, Galovich J, Hoh R, Sinclair E, Hunt P, McCune JM, Martin JN, Petropoulos CJ, Hecht FM. Deeks SG, et al. J Virol. 2006 Jun;80(12):6155-64. doi: 10.1128/JVI.00093-06. J Virol. 2006. PMID: 16731954 Free PMC article. - Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes.
Ruppach H, Nara P, Raudonat I, Elanjikal Z, Rübsamen-Waigmann H, Dietrich U. Ruppach H, et al. J Virol. 2000 Jun;74(12):5403-11. doi: 10.1128/jvi.74.12.5403-5411.2000. J Virol. 2000. PMID: 10823844 Free PMC article. - Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.
Bures R, Morris L, Williamson C, Ramjee G, Deers M, Fiscus SA, Abdool-Karim S, Montefiori DC. Bures R, et al. J Virol. 2002 Mar;76(5):2233-44. doi: 10.1128/jvi.76.5.2233-2244.2002. J Virol. 2002. PMID: 11836401 Free PMC article. - Antigenic variation of primate lentiviruses in humans and experimentally infected macaques.
Fenyö EM. Fenyö EM. Immunol Rev. 1994 Aug;140:131-46. doi: 10.1111/j.1600-065x.1994.tb00868.x. Immunol Rev. 1994. PMID: 7821925 Review. - Role of humoral factors in the progression of HIV disease.
Füst G, Dierich MP, Hidvégi T. Füst G, et al. Immunol Today. 1995 Apr;16(4):167-9. doi: 10.1016/0167-5699(95)80114-6. Immunol Today. 1995. PMID: 7734041 Review. No abstract available.
Cited by
- Harnessing Natural Mosaics: Antibody-Instructed, Multi-Envelope HIV-1 Vaccine Design.
Sealy RE, Dayton B, Finkelstein D, Hurwitz JL. Sealy RE, et al. Viruses. 2021 May 11;13(5):884. doi: 10.3390/v13050884. Viruses. 2021. PMID: 34064894 Free PMC article. - Vaccine Design Informed by Virus-Induced Immunity.
Penkert RR, Hankins JS, Young NS, Hurwitz JL. Penkert RR, et al. Viral Immunol. 2020 May;33(4):342-350. doi: 10.1089/vim.2019.0138. Epub 2020 May 5. Viral Immunol. 2020. PMID: 32366204 Free PMC article. Review. - How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine.
Slobod KS, Hurwitz JL. Slobod KS, et al. Viral Immunol. 2020 Apr;33(3):233-236. doi: 10.1089/vim.2019.0203. Viral Immunol. 2020. PMID: 32286171 Free PMC article. - Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome.
Hurwitz JL, Bonsignori M. Hurwitz JL, et al. Viral Immunol. 2018 Mar;31(2):124-132. doi: 10.1089/vim.2017.0144. Epub 2018 Jan 9. Viral Immunol. 2018. PMID: 29315059 Free PMC article. Review. - Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins.
Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL. Sealy RE, et al. Viral Immunol. 2016 Jan-Feb;29(1):64-70. doi: 10.1089/vim.2015.0078. Epub 2015 Nov 6. Viral Immunol. 2016. PMID: 26544795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical